Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04799015 · ClinicalTrials.gov registry record · Phase 4
Dexamethasone for Post Traumatic Headache
A Phase 4 study of Post-Traumatic Headache, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT04799015: Completed Phase 4 study of Post-Traumatic Headache, sponsored by Montefiore Medical Center.
NCT04799015 is a Phase 4 study of Post-Traumatic Headache that has completed, run by Montefiore Medical Center. The registered enrollment target is 162 participants, roughly in line with the 159-participant average among 11 other Post-Traumatic Headache trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04799015, a Phase 4 study of Post-Traumatic Headache, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized study of intravenous metoclopramide + intravenous dexamethasone versus intravenous metoclopramide for patients with acute post-traumatic headache.
Primary Outcome
Headache intensity will be rated based on the International Headache Society (IHS) 4-point scale. Using this scale participants will verbalize whether their headache intensity is "Severe," "Moderate," "Mild," or "None." The percentage of patients reporting a headache intensity level of either "Moderate" or "Severe" will be grouped and summarized by study arm. The number/percentage of patients reporting a headache intensity level of "Mild" or "None" will also be grouped and summarized by study ar
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Metoclopramide 10mg
Study Locations (1)
New York
- Montefiore - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2024-12-22 |
| Phase | Phase 4 |
What the finished NCT04799015 record still lists
NCT04799015 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 159-participant average among 11 other Post-Traumatic Headache trials with a reported enrollment target.
The record links to 1 condition, with Post-Traumatic Headache appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT04799015 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04799015 about?
NCT04799015 is a clinical study titled "Dexamethasone for Post Traumatic Headache". This is a randomized study of intravenous metoclopramide + intravenous dexamethasone versus intravenous metoclopramide for patients with acute post-traumatic headache.
What is the current status of trial NCT04799015?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 162 participants. The study started on 2021-02-24. Estimated completion is 2024-12-22.
What conditions does trial NCT04799015 study?
This clinical trial studies the following conditions: Post-Traumatic Headache.
What interventions are being tested in trial NCT04799015?
The interventions under investigation include: Dexamethasone (DRUG), Metoclopramide 10mg (DRUG).
Who is sponsoring clinical trial NCT04799015?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04799015 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Traumatic Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04799015's enrollment target sits among peer trials
162 5th of 11 higher than 7 of 11 other Post-Traumatic Headache trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Traumatic Headache trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
RECRUITING · NA
-
Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1
RECRUITING · Phase 1
-
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
RECRUITING · Phase 2
-
Multisite Advancement of Research on Chronic Posttraumatic Headache
RECRUITING · NA
-
Ketamine, SGB and Combination Treatment for TBI
RECRUITING · Phase 2
-
e-CBT DTx for Post Traumatic Headaches in Adults With History of TBI
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI